Evidence-Based Complementary and Alternative Medicine / 2018 / Article / Tab 2 / Research Article
Traditional Chinese Medicine Integrated with Chemotherapy for Stage II-IIIA Patients with Non-Small-Cell Lung Cancer after Radical Surgery: A Retrospective Clinical Analysis with Small Sample Size Table 2 Patient base-line characteristics.
Characteristic TCM user group(N=32) non-TCM user group(N=35) p Sex, (%) Male 21 (65.62) 26(74.29) Female 11(34.38) 9(25.71) 0.439 Age, yr, (%) ≤50 5(15.63) 5(14.29) 50-65 20(62.50) 20(57.14) >65 7(21.87) 10(28.57) 0.820 Smoking status, (%) Never smoked 12(37.50) 12(34.29) <400 14(43.75) 12(34.29) ≥400 6(18.75) 11(31.42) 0.474 ECOG performance status score—no. (%) 0 0 2(5.71) 1 27(84.38) 27(77.14) 2 5(15.62) 6(17.14) 0.375 Tumor size, (%) <5cm 14(43.75) 17(48.57) ≥5cm 18(56.25) 18(51.43) 0.693 Histologic diagnosis, (%) Adenocarcinoma 23(71.88) 21(60.0) Squamous-cell carcinoma 9(28.12) 12(34.28) Adenosquamous carcinoma 0 1(2.86) Other 0 1(2.86) 0.496 Clinical stage, (%) IIA 6(18.75) 13(37.14) IIB 14(43.75) 9(25.71) IIIA 12(37.50) 13(37.14) 0.167 modus operandi, (%) thoracotomy 17(53.13) 18(51.43) Thoracoscopy minimally invasive 14(43.75) 15(42.86) Combined 1(3.12) 2(5.71) 0.877